1. Home
  2. EVC vs PLYX Comparison

EVC vs PLYX Comparison

Compare EVC & PLYX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Entravision Communications Corporation

EVC

Entravision Communications Corporation

HOLD

Current Price

$3.02

Market Cap

273.8M

Sector

Industrials

ML Signal

HOLD

PLYX

Polaryx Therapeutics Inc. Common Stock

N/A

Current Price

$5.73

Market Cap

262.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
EVC
PLYX
Founded
1996
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Broadcasting
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
273.8M
262.3M
IPO Year
2000
N/A

Fundamental Metrics

Financial Performance
Metric
EVC
PLYX
Price
$3.02
$5.73
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$10.00
AVG Volume (30 Days)
358.1K
2.3M
Earning Date
05-07-2026
05-22-2026
Dividend Yield
6.62%
N/A
EPS Growth
47.59
N/A
EPS
N/A
N/A
Revenue
$536,034,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.76
$2.20
52 Week High
$3.68
$9.18

Technical Indicators

Market Signals
Indicator
EVC
PLYX
Relative Strength Index (RSI) 47.52 48.16
Support Level $2.85 $2.37
Resistance Level $3.17 $7.43
Average True Range (ATR) 0.11 1.22
MACD -0.01 0.03
Stochastic Oscillator 17.39 20.73

Price Performance

Historical Comparison
EVC
PLYX

About EVC Entravision Communications Corporation

Entravision Communications Corp owns and operates Spanish language television and radio stations in the United States. The Company also owns and operates a smaller group of television stations that broadcast English language programming and has operations that provide programmatic advertising technology and services. The Company has organized its operations into two reportable segments. Its media segment includes its television, radio, and digital marketing operations. Its advertising and technology services segment provides programmatic advertising and technology services. The company generates the majority of its revenue from the Media segment. Geographically, the company generates the majority of its revenue from the United States.

About PLYX Polaryx Therapeutics Inc. Common Stock

Polaryx Therapeutics Inc is a clinical-stage biotechnology company committed to the discovery, development, and commercialization of novel, disease-modifying therapies for rare, pediatric LSDs. Its therapeutic approach focuses on treating the underlying pathophysiology of these diseases and addressing unmet needs. The company's therapeutic pipeline includes PLX-200, PLX-300, and PLX-100, which are orally available small molecule drug candidates designed to address core pathological mechanisms common to LSDs.

Share on Social Networks: